PISCATAWAY, N.J., Jan. 6, 2026 -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San Francisco Marriott Marquis, with both in-person and virtual attendance options available. Now in its fifth year, GenScript Biotech Global Forum has become a convening platform to push the boundaries of what's possible for the global biotech ecosystem. Held alongside the annual J.P. Morgan Healthcare Conference week, the Forum brings together the s
Healthcare Holding Schweiz AG, a leading service provider and distributor of medical technology in Switzerland, expands its portfolio through the acquisition of a majority stake in Medddbase International AG, which includes Medddbase Schweiz AG and Medddbase Deutschland GmbH. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH and KKA Partners. BAAR, Switzerland, Jan. 6, 2026 -- Healthcare Holding Schweiz AG has successfully acquired a majority interest in Medddbase International AG, headquartered in Buchs, St. Gallen. Medddbase is a highly specialized service pro
Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient care LONDON, Jan. 6, 2026 -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch report, identifying eleven therapies expected to deliver significant clinical impact and strong commercial potential over the coming year. The annual analysis highlights therapies expected to reshape treatment approaches across metabolic disease, oncology, immunology, rare conditions and neurological dis
SHANGHAI, Jan. 6, 2026 -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate Chloride and Dexmethylphenidate Hydrochloride Capsules (Azstarys®) for treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older in China. Azstarys® is a central nervous system stimulant indicated for the treatment of ADHD. Each once-daily capsule contains serdexmethylphenidate (SDX), a prodrug of dexmethy
NEW YORK, Jan. 6, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + NYSE Visits CES 2026 in Las Vegas to Talk AI, Tech, Robotics Kristen Scholer delivers the pre-market update on January 6th Stocks are little changed Tuesday morning after the Dow closed at a record high Monday. Investors maintain a risk-on appetite, especially buying technology shares during the first
LAS VEGAS, Jan. 6, 2026 -- At CES 2026, Segway introduced its new e-bike and e-dirt bike lines for the North American market, marking the brand's evolution from a short-distance transportation pioneer to a global leader in intelligent mobility technology. Guided by its mission,"Simply Moving," Segway simplifies how people and goods move through intuitive, efficient, and intelligent mobility solutions. Backed by more than 16,000 patents, Segway has built strong technical foundations across mobility and robotics, with products in over 160 countries and a global user bas
[ 메디채널 황정호 기자 ] The partnership will see new and enhanced digital experiences served up for fans of The Championships, Wimbledon, enabled by IBM-led transformation and powered by AI LONDON, Jan. 6, 2026 -- IBM (NYSE: IBM) and The All England Lawn Tennis Club today announced a multi-year renewal of their long-standing, landmark technology partnership. From the launch of the Wimbledon website in 1995 and the mobile application in 2009, to the first integration of enhanced AI-powered solutions in 2017, IBM and the All England Club have collaborated for 36 years to deepen global fan enga
경제
Astronergy、グループ・レベルでEcoVadisプラチナ認証を取得、世界トップ1%にランクイン
경제
J&T Express Hits Record 30 Billion Parcel Volume in 2025 with 22.2% YoY Growth
엔터
Samsung Outlines the Impact FAST, Creators and Live Experiences Are Having on the Future of Television at CES 2026
홍콩, 2025년 12월 30일 -- 아시아태평양 지역 사업자들은 향후 1년간 자신의 경제 여건이 개선될 것이라는 기대가 높은 것으로 나타났다. 비(非)사업자에 비해 경제와 건강을 스스로 관리할 수 있다는 인식도 뚜렷해, 삶 전반에 대한 자신감과 주도성이 두드러졌다는 분석이다. 건강 및 웰니스 뉴트리션 전문 글로벌 기업 허벌라이프(Herbalife)가 지난 17일 '2025 아시아태평양 건강 및 경제 역량 인식 조사' 결과를 발표했다. 지난 10월 실시된 '2025 아시아태평양 건강 및 경제 역량 인식 조사'는 호주, 홍콩, 인도네시아, 일본, 한국, 말레이시아, 필리핀, 싱가포르, 대만, 태국, 베트남 등 11개 국가에서 사업자 2,245명을 포함해 총 8,505명을 대상으로 진행됐다. 조사에서 '건강 역량'은 '자신의 신체적, 정신적, 정서적 웰빙 향상에 도움이 되는 결정을 내릴 수 있는 능력'으로, '경제 역량'은 '재정적 안정성을 높이는 능력'으로 정의했다. 조사에 따르면 아태 지역 사업자 응답자 가운데 74%는 향후 12개월 이내 경제적 여건이 개선될 것으로 내다보며, 같은 질문에 긍
SYDNEY, Dec. 30, 2025 -- Australia's sauna market experienced strong growth in 2025, reflecting a broader shift toward preventative health, recovery and long-term wellness investment. According to SDS Australia, one of the nation's leading premium sauna retailers, demand has accelerated across both residential and commercial sectors. Across the country, saunas are now increasingly being integrated into private homes, architectural builds, hospitality venues and high-end wellness spaces. Industry observers say the rising awareness of heat therapy's health benefits, combined with a growi
KUALA LUMPUR, Malaysia, Dec. 25, 2025 -- A significant shift is underway in the regional health and wellness landscape as the innovative Life-Space TrioBiotic supplement series officially enters the Southeast Asian market. The launch introduces a cutting-edge "three-in-one" approach to gut health, combining prebiotics, probiotics, and postbiotics in a single daily dose. The world of health and wellness has been fundamentally transformed by the pivotal role of Probiotics in supporting gut health and overall well-being. Over the past decade, we have witnessed an explosive surge